Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy of omega-3 in the treatment of polycystic ovary syndrome.
Oner G, Muderris II. Oner G, et al. J Obstet Gynaecol. 2013 Apr;33(3):289-91. doi: 10.3109/01443615.2012.751365. J Obstet Gynaecol. 2013. PMID: 23550861 Clinical Trial.
The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome.
Acmaz G, Cınar L, Acmaz B, Aksoy H, Kafadar YT, Madendag Y, Ozdemir F, Sahin E, Muderris I. Acmaz G, et al. Biomed Res Int. 2019 Apr 7;2019:2513067. doi: 10.1155/2019/2513067. eCollection 2019. Biomed Res Int. 2019. PMID: 31080813 Free PMC article.
Effects of hysterectomy on ovarian morphology and serum FSH level in rats.
Ozdamar S, Ulger H, Sorkun HC, Müderris I. Ozdamar S, et al. Maturitas. 2005 Sep 16;52(1):60-4. doi: 10.1016/j.maturitas.2004.12.004. Maturitas. 2005. PMID: 16143226
Low-dose (2.5 mg/day) finasteride treatment in hirsutism.
Bayram F, Müderris I, Güven M, Ozçelik B, Keleştimur F. Bayram F, et al. Gynecol Endocrinol. 2003 Oct;17(5):419-22. doi: 10.1080/09513590312331290328. Gynecol Endocrinol. 2003. PMID: 14710591 Clinical Trial.
Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism.
Bayram F, Müderris II, Güven M, Keleştimur F. Bayram F, et al. Eur J Endocrinol. 2002 Oct;147(4):467-71. doi: 10.1530/eje.0.1470467. Eur J Endocrinol. 2002. PMID: 12370107 Clinical Trial.
RESULTS: The hirsutism scores decreased significantly at months 6 and 12 from a mean+/-s.d. of 18.4+/-4.6 to 13.3+/-5.2 (P<0.001) and 18.4+/-4.6 to 8.6+/-4.2 (P<0.001) in group I and from 18.7+/-5.2 to 13.9+/-5.3 (P<0.001) and 18.7+/-5.2 to 10.3+/-5.0 (P<0.001) in gro …
RESULTS: The hirsutism scores decreased significantly at months 6 and 12 from a mean+/-s.d. of 18.4+/-4.6 to 13.3+/-5.2 (P<0.001) and 18. …
New alternative treatment in hirsutism: bicalutamide 25 mg/day.
Müderris II, Bayram F, Ozçelik B, Güven M. Müderris II, et al. Gynecol Endocrinol. 2002 Feb;16(1):63-6. Gynecol Endocrinol. 2002. PMID: 11915584
Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day).
Müderris II, Bayram F, Güven M. Müderris II, et al. Gynecol Endocrinol. 2000 Feb;14(1):38-41. doi: 10.3109/09513590009167658. Gynecol Endocrinol. 2000. PMID: 10813105 Clinical Trial.
Finasteride treatment for one year in 35 hirsute patients.
Bayram F, Müderris II, Sahin Y, Keleştimur F. Bayram F, et al. Exp Clin Endocrinol Diabetes. 1999;107(3):195-7. doi: 10.1055/s-0029-1212097. Exp Clin Endocrinol Diabetes. 1999. PMID: 10376445 Clinical Trial.
34 results
Jump to page
Feedback